To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
155 Current news from australia
rss
Nanotechnology helps track and improve drug action in pancreatic cancer
13-06-2013
UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques. In real time and in three dimensions, these technologies can show us how cancers spread and how active ...
Chicken pox vaccine saving children's lives
14-03-2013
The widespread introduction of a chicken pox vaccine in Australia in 2006 has prevented thousands of children from being hospitalized with severe chicken pox and saved lives, according to new research. In a national study of chicken pox admissions at four participating Australian children's ...
Breakthrough in battle against leukemia
Griffith University researchers find cancer cell weakness
14-03-2013
Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments. The research team has demonstrated that leukaemic cells can be ...
Persistence pays off in solving hemophilia mystery, showing curiosity drives discovery
11-03-2013
An Australian researcher has found the third and final missing piece in the genetic puzzle of an unusual form of hemophilia, more than 20 year after he discovered the first two pieces. Professor Merlin Crossley, of the University of New South Wales, and his international team studied the ...
Pathway controlling cell growth revealed
19-02-2013
A Melbourne-based research team has discovered a genetic defect that can halt cell growth and force cells into a death-evading survival state. The finding has revealed an important mechanism controlling the growth of rapidly-dividing cells that may ultimately lead to the development of new ...
Nothing fishy about swimming with same-sized mates
Same-sized fish stick together, using chemical cues to identify each other
07-02-2013
Have you ever wondered why, and how, shoals of fish are comprised of fish of the same size? According to new research by Ashley Ward, from the University of Sydney in Australia, and Suzanne Currie, from Mount Allison University in Canada, fish can use a variety of different sensory cues to ...
Cellmid records positive data in midkine antibody study in kidney disease
30-01-2013
Cellmid Limited has completed its first in-life diabetic nephropathy study with the Company’s anti-midkine antibodies (MK-Ab) in a mouse model of the disease. Two of Cellmid’s proprietary MK-Ab’s were tested. Both antibodies reduced kidney damage significantly, as assessed by functional and ...
Abraxane plus gemcitabine improves survival in phase III study of patients with advanced pancreatic cancer
30-01-2013
Specialised Therapeutics Australia announced that a phase III clinical trial of breast cancer drug ABRAXANE® (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved ...
Mesoblast’s Neofuse stem cell product shows positive results in Phase 2 lumbar fusion trial
Results support progression of clinical development to Phase 3
16-01-2013
Mesoblast Limited announced that its Phase 2 clinical trial for lumbar spinal fusion had met its safety and efficacy endpoints. The results suggest that Mesoblast’s NeoFuse product comprising allogeneic Mesenchymal Precursor Cells (MPCs) is as effective for interbody lumbar fusion as the gold ...
Biotron completes clinical stage of HIV clinical trial
21-12-2012
Biotron Limited (BIT) has completed the clinical stage of a landmark phase 1b/2a proof-of-concept human trial of its lead HIV drug candidate, BIT225. The placebo-controlled, double-blinded study was undertaken at a clinical trial unit in Bangkok, Thailand. Patients enrolled in the trial were ...
Netmeeting
